SAN DIEGO — Patients with migraine who received daytime psilocybin experienced reduced REM sleep, with effects lasting beyond the day of administration, according to a poster at the American Headache Society Annual Scientific Meeting.
“This project was done to start exploring a potential source for psilocybin’s lasting therapeutic effects in migraine,” Emmanuelle A.D. Schindler, MD, PhD, medical director of the VA Connecticut Headache Center of Excellence and assistant professor of neurology at Yale School of Medicine, told Healio. “In earlier studies and in